Reich Olaf, Liegl Bernadette, Tamussino Karl, Regauer Sigrid
Department of Obstetrics and Gynecology, Medical University of Graz, Austria.
Mod Pathol. 2005 Mar;18(3):354-7. doi: 10.1038/modpathol.3800243.
We evaluated p186Her2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease. We identified six patients with recurrent vulvar Paget's disease in our archives. The number of recurrences ranged from 1 to 11 over a time period of 1-168 months. Recurrences were evaluated immunohistochemically for p185Her2 overexpression with the HercepTest and for HER2 oncogene amplification with fluorescence in situ hybridization. p185Her2 overexpression was scored as 3 in two patients, as 2 in two patients, and as 1 in two patients. All patients with scores 2 and 3 showed HER2 oncogene amplification. Overexpression of p185Her2 and HER2 oncogene amplification appears to be common in recurrent vulvar Paget's disease.
我们评估了复发性外阴佩吉特病中p186Her2过表达和HER2癌基因扩增情况。我们在档案中识别出6例复发性外阴佩吉特病患者。复发次数在1至11次之间,时间跨度为1至168个月。采用HercepTest免疫组化法评估复发灶中p185Her2过表达情况,采用荧光原位杂交法评估HER2癌基因扩增情况。2例患者p185Her2过表达评分为3分,2例患者评分为2分,2例患者评分为1分。所有评分为2分和3分的患者均显示HER2癌基因扩增。p185Her2过表达和HER2癌基因扩增在复发性外阴佩吉特病中似乎很常见。